Corporate responsibility Archives

MSD donates $500,000 to support river blindness and lymphatic filariasis elimination efforts

Grants will be administered through the MECTIZAN® Donation Program and will support precautionary measures required to prevent the spread of SARS-CoV-2 during mass drug administration programs for these two diseases

October 22, 2020

MSD publishes 2019/2020 corporate responsibility report

Letter from our chairman and CEO, Ken Frazier

October 14, 2020

Celebrating MSD’s first Global Patient Week

During our inaugural Global Patient Week (October 5–9), we will celebrate the journeys of patients by sharing their stories and giving them a voice.

October 5, 2020

Your questions answered: How MSD is responding to the COVID-19 pandemic

October 1, 2020

Tackling health disparities through impact investing

Ken Gustavsen, strategy officer, Social Business Innovation, and impact investing portfolio manager, offers three lessons on helping advance global health goals

September 21, 2020

How diversity and inclusion is essential to our mission

By Celeste Warren, vice president of human resources and chief diversity officer

August 3, 2020

Inclusivity as key ingredient in resiliency

with Don Watson, vice president, global workforce and enterprise services

July 21, 2020

Our disability inclusiveness earns top employer award

Learn how we maximize potential by making employees across all dimensions of ability feel valued and empowered.

July 16, 2020

Keelee's maternal health journey

A post-partum infection that threatened her life inspires Keelee to share her story with others.

July 14, 2020

The Ebola outbreak centered in the eastern region of the Democratic Republic of Congo has come to an end

July 7, 2020

Heart failure: A physician’s perspective

Driven to make a difference By Dr. Joerg Koglin, vice president, therapeutic area head, global clinical development, cardiovascular, MSD Research Laboratories

June 15, 2020